TP53 and astrocytoma (excluding glioblastoma): In this HTS, however, a unique collection of 68,427 pre-fractionated and partially purified natural product extracts was screened against Trp53/Nf1 mutant astrocytoma cells derived from the Nf1−/+; Trp53−/+ cis mouse model [134].